Tommy John, the veteran left‑hander whose 26‑year Major League Baseball career spanned three decades, passed away on Tuesday at the age of 83. Known for his durability and a 3.34 career earned‑run average, John’s name became inseparable from a surgical breakthrough that altered the trajectory of countless pitchers.
A career of resilience
Over 288 victories and 12 All‑Star selections marked John’s journey, which included stints with the Cleveland Indians, Los Angeles Dodgers, New York Yankees, California Angels, Oakland Athletics and the New York Mets. His 288 wins rank second among non‑Hall of Fame pitchers of the modern era, trailing only Roger Clemens.
The surgery that rewrote pitching medicine
In 1974, while pitching against the Montreal Expos, John tore his ulnar collateral ligament. Dr. Frank Jobe performed the first reconstructive operation, transplanting a tendon from John’s forearm to repair the damaged ligament. The procedure, initially viewed as experimental, allowed John to return in 1976 and pitch another 14 seasons, adding three more All‑Star appearances to his résumé.
A lasting impact
The operation, now universally known as Tommy John surgery, has been performed on more than 1,000 professional pitchers by 2024, with 35.3% of active MLB arms having undergone the procedure by 2023. Its prevalence has turned what was once a career‑ending injury into a routine recovery, reshaping training regimens and contract negotiations across the league.
Roots and early life
Born in Terre Haute, Indiana, John honed his athletic talents at Gerstmeyer High School before signing with the Cleveland Indians at 18. His early exposure to both baseball and basketball forged the competitive spirit that later defined his professional tenure.